CA2754281C - Antiviral combination of zinc and trimethoprim - Google Patents

Antiviral combination of zinc and trimethoprim Download PDF

Info

Publication number
CA2754281C
CA2754281C CA2754281A CA2754281A CA2754281C CA 2754281 C CA2754281 C CA 2754281C CA 2754281 A CA2754281 A CA 2754281A CA 2754281 A CA2754281 A CA 2754281A CA 2754281 C CA2754281 C CA 2754281C
Authority
CA
Canada
Prior art keywords
infection
zinc
trimethoprim
composition
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2754281A
Other languages
English (en)
French (fr)
Other versions
CA2754281A1 (en
Inventor
Magdi El Habbal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2754281A1 publication Critical patent/CA2754281A1/en
Application granted granted Critical
Publication of CA2754281C publication Critical patent/CA2754281C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2754281A 2008-03-03 2009-02-27 Antiviral combination of zinc and trimethoprim Active CA2754281C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0803948.9A GB0803948D0 (en) 2008-03-03 2008-03-03 Combination therapy
GB0803948.9 2008-03-03
PCT/EP2009/052394 WO2009109531A2 (en) 2008-03-03 2009-02-27 Combination therapy

Publications (2)

Publication Number Publication Date
CA2754281A1 CA2754281A1 (en) 2009-09-11
CA2754281C true CA2754281C (en) 2016-12-06

Family

ID=39315874

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2754281A Active CA2754281C (en) 2008-03-03 2009-02-27 Antiviral combination of zinc and trimethoprim

Country Status (11)

Country Link
US (1) US10045984B2 (https=)
EP (1) EP2257292B1 (https=)
JP (1) JP5587215B2 (https=)
CN (1) CN101998856A (https=)
CA (1) CA2754281C (https=)
CY (1) CY1115555T1 (https=)
DK (1) DK2257292T3 (https=)
ES (1) ES2507570T3 (https=)
GB (1) GB0803948D0 (https=)
PT (1) PT2257292E (https=)
WO (1) WO2009109531A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2740657C1 (ru) * 2020-05-15 2021-01-19 Общество С Ограниченной Ответственностью "Промомед Рус" Противовирусная композиция
NL2028566B1 (nl) * 2021-06-29 2023-01-09 Simons Care Innovation Group B V Een zinkzout huidpleister en werkwijzen
JP7287730B2 (ja) * 2021-10-12 2023-06-06 ローバル株式会社 ウイルスを不活化可能な高濃度亜鉛末塗料

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4125610A (en) * 1977-07-27 1978-11-14 Bristol-Myers Company Antibacterial compositions
US5637311A (en) * 1995-06-29 1997-06-10 Procyte Corporation Zinc(II) complexes and methods related thereto

Also Published As

Publication number Publication date
US10045984B2 (en) 2018-08-14
ES2507570T3 (es) 2014-10-15
GB0803948D0 (en) 2008-04-09
EP2257292A2 (en) 2010-12-08
DK2257292T3 (da) 2014-09-29
PT2257292E (pt) 2014-10-22
CN101998856A (zh) 2011-03-30
US20110045070A1 (en) 2011-02-24
EP2257292B1 (en) 2014-07-16
WO2009109531A3 (en) 2009-11-12
JP5587215B2 (ja) 2014-09-10
CA2754281A1 (en) 2009-09-11
CY1115555T1 (el) 2017-01-04
JP2011513356A (ja) 2011-04-28
WO2009109531A2 (en) 2009-09-11

Similar Documents

Publication Publication Date Title
EP2983667B1 (en) Nhe3-binding compounds and methods for inhibiting phosphate transport
RU2071323C1 (ru) Противовирусный препарат "полирем"
JP2025013684A (ja) 重度腎機能障害を有する癌患者に対する治療方法
US20240285643A1 (en) Treating influenza using substituted polycyclic pyridone derivatives and prodrugs thereof in a subject having influenza and a severe influenza condition
CA2754281C (en) Antiviral combination of zinc and trimethoprim
ES2280259T3 (es) Complejos de galio de 3-hidroxi-4-pironas para tratar infecciones por procariotas intracelulares, virus de adn y retrovirus.
US6638915B1 (en) Anti-viral composition
NL194430C (nl) Niet-injecteerbaar farmaceutisch preparaat met anti-kankerwerking.
WO2020194042A1 (en) Treating influenza using substituted polycyclic pyridone derivatives and prodrugs thereof in a subject having influenza and a severe influenza condition
JPS6333332A (ja) エイズ・ウイルス増殖抑制剤
EP3720440A1 (en) Treatment of rsv with combination product
CN116549455A (zh) PLK4抑制剂Centrinone在制备治疗包虫病药物中的应用
JP3150642B2 (ja) 新規な抗痙攣性及び抗炎症性組成物並びにそれらの製造方法
WO1993001817A1 (en) Antiviral compositions comprising fusidic acid, l-ascorbic acid and salicylic acid and derivatives
CN120983444B (zh) 一种抗食管鳞癌药物组合物
JP7758278B2 (ja) コロナウイルス科感染症の治療又は予防
US20240009214A1 (en) Method of Treating Viral Infection
WO2025038636A1 (en) Antiviral supplement formulations for herpesvirus infections
UA146741U (uk) Спосіб лікування бетакоронавірусної інфекції
Rescue et al. Phase II Clinical Trial With High-Dose Methotrexate Therapy and
Olney Relenza: generic name: zanamivir
CN101084893A (zh) 一种抗呼吸道病毒的药物及用途
HK1221400B (en) Nhe3-binding compounds and methods for inhibiting phosphate transport

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20140224

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-4-4-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251023

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-H100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE AND LATE FEE NOT PAID BY DEADLINE OF NOTICE

Effective date: 20260203

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260209